Figure 7.
The molecular regulatory mechanism underlying UA’s anticancer activity in NSCLC cells, and UA’s inhibition of the EGFR/JAK2/STAT3 signaling pathway and PD-L1. Continuous black point arrow denotes the activity of UA, dotted point arrows denotes blockage of signals, and red block arrow denotes the inhibition of EGFR signaling by UA.
